Rising healthcare costs to spur little action before 2020, analysts say
Affordability concerns are impacting the healthcare of a growing number of Americans, according to new polling. However, there is little chance that Congress will address that issue before the 2020 election, political analysts say.
Geisinger clinical effectiveness program credited with stabilizing biologics costs
Biologics comprised less than 1% of Geisinger Health’s claims but were approaching 50% of its total drug spending. That is, until a comparative effectiveness program halted the rapid increase.
Five Tactics to Boost Clinical-Financial Alignment Toward EHR Data Efficiency
Dan O’Connor offers five tactics to help optimize technology investments to meet the evolving expectations of both end-users and patients.
Why Hospitals Are Optimistic About Prospects for Star Ratings Overhaul
Hospital advocates hope an appeal tuned to the Trump administration’s focus on reducing costly and time-consuming provider burdens will pay off in an overhaul of the hospital star-rating system.
HFMA Offers Recommendations to Senate to Reduce Total Cost of Care while Improving Patient Outcomes
This letter contains HFMA's recommendations to the Senate HELP committee on ways to reduce the total cost of care while improving patient outcomes.
Introducing a Road Map for Advanced Cost Accounting
HFMA President and CEO Joe Fifer discusses the new cost accounting model launched as a collaboration between HFMA and Strata Decision Technology.
Toward a More Effective Way of Validating Cost Data
Although there are no industry standards for measuring costing accuracy, financial analysts can take steps to ensure the cost number accurately reflects to the true cost of an item.
Annual Hospital Costs for Opioid Overdose Patients Approaches $2 Billion
The average cost for an overdose patient who was treated and released totaled $504, but the average cost rose to $11,731 for those that were treated and admitted to a hospital.
Evaluating Cost-of-Care Progress
Although more time and evidence are needed to prove the efficacy of population-based VBP models, there are other models that may be more appropriate for different populations.
Q&A: Executives Discuss Cost Accounting Obstacles, Opportunities
Feb. 15—Hospitals and health systems are increasingly pushing to better identify and reduce costs of care.